leisure time -WSS

leisure time

author：fashion 2025-08-23 23:21:36 - browse：82

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Why medical students are struggling with mental health

Wikipedia

WSS

FDA's Woodcock to retire early next year

A daunting task: navigating dual Medicare, Medicaid eligibility

Medicare must police algorithms in Medicare Advantage, Dems say

David Sabatini, ex

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Astellas still sees hope in its gene therapy after four deaths

hotspot

leisure time

Wikipedia

Drug repurposing or repositioning? The language matters

Prime Medicine says its gene editing passes test in monkeys

Moonlake's readout produced a cash windfall. Risks remain

David Sabatini, ex

Medical records are filled with copy

Kidney transplant patients stopped immunosuppressants in trial

Hollywood unions extend contract negotiations for actors

Kidney transplant patients stopped immunosuppressants in trial

Alkermes shareholders re

Inari Medical to buy amputation prevention company LimFlow

hotspot

Congress must reauthorize a committee to support older Americans

Astellas still sees hope in its gene therapy after four deaths

Travis Kelce and the trap of celebrity vaccine endorsements

David Sabatini, ex

David Sabatini, ex

Key Senate panel to consider PBM, drug pricing reform package

entertainment

hotspot

entertainment

hotspot